PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target

Abstract Aberrant overexpression or activation of EGFR drives the development of non-small cell lung cancer (NSCLC) and acquired resistance to EGFR tyrosine kinase inhibitors (TKIs) by secondary EGFR mutations or c-MET amplification/activation remains as a major hurdle for NSCLC treatment. We previo...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shaifali Singh, Nai Yang Yeat, Ya-Ting Wang, Shu-Yu Lin, I-Ying Kuo, Kuen-Phon Wu, Won-Jing Wang, Wen-Ching Wang, Wu-Chou Su, Yi-Ching Wang, Ruey-Hwa Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Publishing Group 2023-10-01
Colecção:	Cell Death and Disease
Acesso em linha:	https://doi.org/10.1038/s41419-023-06201-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!